订阅小程序
旧版功能

A Phase I/Ib Open-Label, First-in-human, Single Agent, Dose Escalation and Expansion Study of a HER2-targeted T Cell Engager (SAR443216) in Patients with Relapsed/refractory HER2-expressing Solid Tumors

E. E. Dumbrava,E. Calvo,E. Garralda,M. H. Ryu, D. Y. Oh,L. Y. Bai,W. Chung,K. I. Rojas Laimito,O. Yildirim,S. Masciari, K. Kang, B. Buday, F. Rharbaoui,G. Abbadessa,V. Moreno Garcia

ANNALS OF ONCOLOGY（2023）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要